#immuno-oncology Tech News.
1 story in the last 7 days
The latest immuno-oncology news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks immuno-oncology across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
AISeeking Alphaabout 3 hours ago
Compugen CEO on AI-Driven Target DiscoveryCompugen CEO Eran Ophir discussed the company's Unigen engine for end-to-end AI-driven target discovery in immuno-oncology. The platform focuses on identifying first-in-class drug targets at the earliest stage of research and development, a process Compugen has pursued long before AI became a buzzword in biotech.
Summaries by ByteBrief